These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38734698)

  • 1. Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles.
    Bian X; Yang L; Jiang D; Grippin AJ; Ma Y; Wu S; Wu L; Wang X; Tang Z; Tang K; Pan W; Dong S; Kim BYS; Jiang W; Yang Z; Li C
    Nat Commun; 2024 May; 15(1):3987. PubMed ID: 38734698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced blood-brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider.
    Ding J; Sun Y; Li J; Wang H; Mao S
    J Drug Target; 2017 Jul; 25(6):532-540. PubMed ID: 28151022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
    Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
    Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of vinpocetine on cerebral circulation in rats after exposure to radiation].
    Vereshchagin VK
    Eksp Klin Farmakol; 2003; 66(5):14-6. PubMed ID: 14650207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human positron emission tomography with oral 11C-vinpocetine].
    Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
    Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
    Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
    Szakáll S; Boros I; Balkay L; Emri M; Fekete I; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Galuska L; Trón L; Bereczki D; Csiba L; Gulyás B
    J Neuroimaging; 1998 Oct; 8(4):197-204. PubMed ID: 9780850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of vinpocetine against brain damage caused by ischemia.
    Rischke R; Krieglstein J
    Jpn J Pharmacol; 1991 Jul; 56(3):349-56. PubMed ID: 1895579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
    Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
    J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of vinpocetine].
    Kiss B; Kárpáti E
    Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vinpocetine in cerebrovascular diseases.
    Patyar S; Prakash A; Modi M; Medhi B
    Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D
    Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N; Matsumoto S
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine.
    Fandy TE; Abdallah I; Khayat M; Colby DA; Hassan HE
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):259-67. PubMed ID: 26666648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
    Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
    Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A
    Brain Res Bull; 2000 Oct; 53(3):245-54. PubMed ID: 11113577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
    Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
    Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.